Welcome to medications.com

Kenalog Information

What's inside Kenalog

Kenalog Active Ingredients: triamcinolone acetonide, details.
Kenalog Dosages & Strengths
Strength Format Route Strength Class
Kenalog 0.1% ointment topical 100.0 gram(s) OTC
Kenalog 0.147 mg/g spray topical 1.0 gram(s) OTC
Kenalog 0.1% lotion topical 100.0 milliliter(s) OTC
Kenalog 0.025% lotion topical 100.0 milliliter(s) OTC
Kenalog 0.1% cream topical 100.0 gram(s) OTC
Kenalog 0.025% cream topical 100.0 gram(s) OTC
Kenalog 0.5% cream topical 100.0 gram(s) OTC

Recent Kenalog Side Effects

Posted by gardner1001 3 days ago
October 3, 2008...went to doctor and received a Kenalog shot..because 20 years ago I had started with spots on my arms and fo...

Posted by kenhol 4 days ago
I made an appt. with my gyno. about six weeks ago because my period was going on for two weeks at a time. Around that time m...

Posted by researcher 4 days ago
My sister had this exact thing happen to her and the nurse who posted the saline shots is totally right. It took three doctor...


Kenalog in the News

Endophthalmitis rates low in ongoing intravitreal steroid trials - OSN SuperSite (subscription)
In pooled data from seven other studies involving 3248 patients treated with intravitreal injections of Kenalog (triamcinolone, Bristol-Meyers Squibb), ...
Fri Jan 25 14:12:43 -0500 2008

Advice: Dr. Donohue - NorthJersey.com
He sent me to an ear, nose and throat doctor, who said the white patches look like lichen planus, and he has me on Kenalog in Orabase. ...
Fri Dec 14 09:56:01 -0500 2007

The FDA Raises Safety Concerns Regarding Off-Label Use of Avastin ... - StreetInsider.com (subscription)
... Therapeutics Drugs Mentioned: - Aflibercept (VEGF Trap) - Avastin (bevacizumab) - Herceptin (trastuzumab) - Kenalog/Kenacort (triamcinolone acetonide, ...
Wed Jan 02 13:37:48 -0500 2008


Kenalog Chemical Information

triamcinolone acetonide - The acetonide salt form of triamcinolone, a synthetic glucocorticosteroid with immunosuppressive and anti-inflammatory activity. Triamcinolone acetonide binds to specific cytosolic glucocorticoid receptors and subsequently interacts with glucocorticoid receptor response element on DNA and alters gene expression. This results in an induction of the synthesis of certain anti-inflammatory proteins while inhibiting the synthesis of certain inflammatory mediators. Consequently, an overall reduction in chronic inflammation and autoimmune reactions are accomplished.





ADVERTISEMENT
© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com